American Association for Cancer Research
Browse
00085472can053055-sup-can-05-3055-tables2.pdf (66.69 kB)

Supplementary Table S2 from Sex-Determining Region Y Box 4 Is a Transforming Oncogene in Human Prostate Cancer Cells

Download (66.69 kB)
journal contribution
posted on 2023-03-30, 17:02 authored by Pengbo Liu, Sumathi Ramachandran, Mohamed Ali Seyed, Christopher D. Scharer, Noelani Laycock, W. Brian Dalton, Holly Williams, Suresh Karanam, Milton W. Datta, David L. Jaye, Carlos S. Moreno
Supplementary Table S2 from Sex-Determining Region Y Box 4 Is a Transforming Oncogene in Human Prostate Cancer Cells

History

ARTICLE ABSTRACT

Prostate cancer is the most commonly diagnosed noncutaneous neoplasm and second most common cause of cancer-related mortality in western men. To investigate the mechanisms of prostate cancer development and progression, we did expression profiling of human prostate cancer and benign tissues. We show that the SOX4 is overexpressed in prostate tumor samples compared with benign tissues by microarray analysis, real-time PCR, and immunohistochemistry. We also show that SOX4 expression is highly correlated with Gleason score at the mRNA and protein level using tissue microarrays. Genes affected by SOX4 expression were also identified, including BCL10, CSF1, and NcoA4/ARA70. TLE-1 and BBC3/PUMA were identified as direct targets of SOX4. Silencing of SOX4 by small interfering RNA transfection induced apoptosis of prostate cancer cells, suggesting that SOX4 could be a therapeutic target for prostate cancer. Stable transfection of SOX4 into nontransformed prostate cells enabled colony formation in soft agar, suggesting that, in the proper cellular context, SOX4 can be a transforming oncogene. (Cancer Res 2006; 66(8): 4011-9)

Usage metrics

    Cancer Research

    Categories

    Keywords

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC